Raiffeisen Bank International »

Recursion Pharmaceuticals shares owned by Raiffeisen Bank International

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Raiffeisen Bank International from 13F filings

Historical chart of Raiffeisen Bank International investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Raiffeisen Bank International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Raiffeisen Bank International

Quarter filed Position value Share count Share price at filing
2026-03-31 $454k 160k 2.84

More positions owned by Raiffeisen Bank International

Nvidia Corp Common Stock (NVDA)
Alphabet Common Stock (GOOGL)
Apple Common Stock (AAPL)
Broadcom Common Stock (AVGO)
Amazoncom Common Stock (AMZN)
Applied Materials Common Stock (AMAT)
Eli Lilly & Co Common Stock (LLY)
Lam Research Corp Common Stock (LRCX)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Jpmorgan Chase & Co Common Stock (JPM)
Cisco Systems Common Stock (CSCO)
Abbvie Common Stock (ABBV)
Visa Common Stock (V)
Quanta Services Common Stock (PWR)
Advanced Micro Devices Common Stock (AMD)

View all positions for Raiffeisen Bank International

Top funds holding Recursion Pharmaceuticals

Vanguard Group
BlackRock
ARK Investment Management
State Street Corporation
Baillie Gifford & Co
Vanguard Portfolio Management
Vanguard Capital Management
Softbank Group Corp
Geode Capital Management
MIC Capital Management UK
Susquehanna International
Goldman Sachs Group
Data Collective IV GP
Exor Investments
Sumitomo Mitsui Trust Holdings

View all funds holding Recursion Pharmaceuticals